Organon & Co (OGN)
18.71
+0.19
(+1.03%)
USD |
NYSE |
Apr 24, 16:00
18.59
-0.12
(-0.64%)
After-Hours: 20:00
Organon Gross Profit Margin (Quarterly): 57.26% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 57.26% |
| September 30, 2023 | 59.71% |
| June 30, 2023 | 60.20% |
| March 31, 2023 | 62.29% |
| December 31, 2022 | 60.00% |
| September 30, 2022 | 64.15% |
| June 30, 2022 | 62.90% |
| March 31, 2022 | 64.20% |
| Date | Value |
|---|---|
| December 31, 2021 | 62.63% |
| September 30, 2021 | 61.94% |
| June 30, 2021 | 63.45% |
| March 31, 2021 | 60.76% |
| December 31, 2020 | 63.67% |
| September 30, 2020 | 66.83% |
| June 30, 2020 | 69.86% |
| March 31, 2020 | 69.78% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
57.26%
Minimum
Dec 2023
69.86%
Maximum
Jun 2020
63.10%
Average
62.77%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 73.26% |
| Alnylam Pharmaceuticals Inc | 80.47% |
| Amgen Inc | 62.03% |
| Biogen Inc | 74.09% |
| Pacira BioSciences Inc | 73.69% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | 9.17% |
| Return on Invested Capital | 12.50% |
| Profit Margin (Quarterly) | 34.17% |
| Operating Margin (Quarterly) | 19.52% |
| Return on Net Operating Assets | 11.31% |